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ABSTRACT

This study investigates how millennials view their relationship with the pharmaceutical
industry and if that relationship changes when exposed to different crisis messaging strategies.
The pharmaceutical industry is currently dealing with a preventable crisis because of companies
in the industry, such as opioid companies, causing death, distrust, and lawsuits. Coombs
suggests the rebuild message strategies will result in a stronger relationship between the
industry and their publics. This study will test that theory. The millennial participants that
contributed to this study were all born between 1980-1996. Their relationships were measured
through the variables of trust, satisfaction, control mutuality, commitment, communal
relationships, and exchange relationships. The experiment was conducted online through
Qualtrics and distributed participants into four groups, each with a different crisis response
strategy in place. Those strategies were, denial, apology, silence, and a control group. The
experiment yielded results that the crisis messaging strategies did not affect how participants
viewed their relationship with the industry. The result enforced that within the millennial
generation their relationship with the pharmaceutical industry is deeply rooted in their beliefs
and cannot be influenced by a single message. This study also reinforced the accuracy in
measuring a relationship and showed there is still much to learn about millennials and the
pharmaceutical industry.

iv

CHAPTER ONE:
INTRODUCTION AND PURPOSE

The purpose of this research is twofold. First, it aims to extend understanding of
situational crisis communication theory and organization-public relationship theory by applying
an integrated study within the pharmaceutical industry. This study will also use situational crisis
communication theory to see what is the most effective crisis response strategy that will
produce the best end relationship between the pharmaceutical industry and its external publics
among millennials. This study hopes to establish a baseline of effective message strategies
when the pharmaceutical industry is faced with a crisis.
The term “big pharma” has been thrown around in the media by the New York Times,
Reuters, Washington Post, NPR, CNN, ABC, and many others. While the coverage over the years
has been a mix of positive and negative stories many of them have headlines of court trials
rather than medical breakthroughs. With major news sources having these type of headlines, it
may be enforcing a lack of trust within the pharmaceutical industry. According to Edelman’s
2019 Trust Barometer, the Pharmaceutical industry is the least trusted industry of healthcare.
Healthcare trust inequality has reached a record high with the gap between informed publics
and the mass population reaching a 10-point gap. This means that while the informed publics of
the whole healthcare industry have a 75% trust rate, the mass population only has a 65% trust
rate. While the subcategory of pharmaceuticals has gained two more trust points since last
1

year, it is still the lowest of all the subcategories of the healthcare industry at only a 57% trust
rate. Since the 2015 Edelman study, the Pharmaceutical industry has continuously been the
least trusted industry of healthcare (2019). This lack of trust is one variable of the problem that
is facing the industry, and that is the possible lack of a relationship with the industries external
publics. This study will elaborate on how the pharmaceutical industry is currently in a
preventable crisis that has been established by different companies that are represented in the
industry, such as opioid companies. The fall out of this crisis have been deaths, distrust, and
lawsuits. Many of these factors affect the publics relationship with the industry and can create
a devastating impact for the industry

Background
When it comes to the pharmaceutical industry in the media, they are mostly seen in
commercial advertisements for their medications. These medications range in treatments for
rare diseases, pain, stimulants, and many others. While this type of media looks to drive
business for the pharmaceutical industry, there are many other sources of media that do not
show the industry in a positive light. This can range from legal ads fighting misuse of the
medications to headlines such as “How Johnson & Johnson companies used a ‘super poppy’ to
make narcotics for America’s most abused opioid pills (Peter Whoriskey, 2020), “Report:
Purdue Pharma involved in kickback investigation (Paul Schott, 2020), and “Purdue Pharma
Tentatively Settles Thousands of Opioid Cases (Jan Hoffman, 2019). There have also been many
streaming service shows and movies showing a negative perception of the industry, such as
Netflix’s The Pharmacist, which looks at a first-hand encounter of how the opioid crisis can
2

affect people’s lives and the conspiracy’s within the industry. Another media platform that has
broadcasted a negative image of the pharmaceutical industry is through politics. Popular
among millennials, candidate Bernie Sander regularly voiced strong opinions against the
industry and referred to them as corrupt “big pharma.”
There are many different ways that people can learn about an organization. They can
learn from personal experience, from what they have heard about it through family and friends,
or they could learn about it from the media. More and more, the world is learning and defining
their relationships with organizations based on second-hand experience they are learning from
the media. In particular, many millennials grew up in the time period where technology and the
media were emerging and becoming the dominant source of information. Authors Howe and
Strauss even refer to the millennial group as “digital natives” (Howe & Strauss, 2009).
Millennials grew up in both a world without modern technology and a world where they have
as much information at their fingertips as they want. According to an article by Lenhart,
“millennials are one of the main groups that use and understand media. They grew up in a
world that’s connected through media and technology that gives them the opportunity to
receive immediate information” (Lenhart et al., 2010). Knowing how connected the millennial
generation is with media plays a key role for many organizations when building relationships
with them.
The distrust with the industry is just one part of the crisis the pharmaceutical industry is
currently facing. Coombs defines a crisis as “a sudden and unexpected event that threatens to
disrupt an organization’s operations and poses both a financial and a reputational threat”
(2007, p. 164). Due to the amount of court cases that have reached the media, including certain
3

companies such as Johnson & Johnson and Purdue Pharma, the public has seen these
companied have to pay over $500 million or even go bankrupt. During the recent democratic
presidential debate candidates such as Bernie Sanders continue to reinforce to the public that
he will “stand up to the greed, corruption, and price fixing of the pharmaceutical industry”.
(Sanders, 2019). Examples like these depict how the industry is being shown to the public and
how their reputation and relationship with the public is in crisis. Without a strong relationship
between the industry and its publics funding for future medicines could be halted and it could
become a lot harder for people to receive the medicines they need. If the industry is able to
build a better relationship with its publics “it will save the industry money by reducing the costs
of litigation, regulation, legislation, pressure campaigns, boycotts, or lost revenue that result
from bad relationships. It will also help the industry make money by cultivating relationships
with donors, consumers, shareholders, and legislators who are needed to support
organizational goals” (Hon & Grunig, 1999).

Theoretical Framework
A relationship between an organization and its publics can vary depending on multiple
factors. A relationship is defined as “the connection between an organization and its public(s)
that needs to be build and maintained over time because of its strengths to impact the
economic, social, cultural, or political well-being of the other” (Ledingham, 2003, p. 184). For
this study, the focus will be on a relationship seen between an organization, the pharmaceutical
industry, and one of its publics, millennials. According to John Migliaccio, millennials are
defined as “anyone who was born between the years of 1980-1996” (Migliaccio, 2019). While
4

there is a debate about which years encompass generation Z, this study will be using the years
defined by Migliaccio. Situational crisis communication theory, which will be described further
in the literature review, will be used to decide on the types of messages that should be used
during a crisis. Since the crisis being examined in this study is a preventable one, Coombs
suggests that the rebuild strategy will yield a stronger relationship between the public and the
industry (Coombs, 2007). The SCCT framework will be tested on its use within the eyes of the
pharmaceutical crisis and potentially expand on the theory.

Importance of Study
This study is not only important to test the theories and frameworks in use but to begin
a discussion around the communication strategies used in the pharmaceutical industry. The
significance of this study will shed light on the industries reputation and their current
relationship with external publics. With the type of statistics coming from Edelman, the crisis of
relationship management in the industry needs to be addressed and researched further. If this
study can show a base line of how the public feels their relationship is with the industry, and
different response strategies are tested, then there is potential for the industry to regain trust.
Seeing how millennials view their trust and relationship with the pharmaceutical industry will
bring new light to how this will affect the industry. Millennials are the future generation that
will be making decisions for the industry, including regulations. In 2017 the US Census Bureau
“announced that there are currently 92 million millennials, and this makes them the largest
living generation” (Gerhardt & Peluchette, 2018). For researches, this is important because they
can see not only how millennials, the largest demographic, measures their trust with the
5

industry but how they are being exposed to the industry and if that has any correlation with
their trust. For the pharmaceutical industry, it is important to know about the relationship all
stakeholders have but especially how the future generation sees themselves in the eyes of an
industry that is known to be distrusted.

Outline of Study
Chapter two will examine the theoretical frameworks applied in this study. It will define
the theories, explain how they are used, and why they are being used in the study. Chapter
three will discuss the methodology that was chosen and why, along with the key components
that will be used. Chapter four will look at the results of the data analysis, which will lead to the
discussion of the results in chapter five. Finally, chapter six will conclude the study by going into
detail about further research on the topic and limitations that were involved.

6

CHAPTER TWO
LITERATURE REVIEW

Organization - Public Relationship Theory
One of the key components between a company, organization, or industry is its
relationship with its stakeholders. The quality of between the two can significantly affect both
parties. A relationship is defined as “the connection between an organization and its public(s)
that needs to be build and maintained over time because of its strengths to impact the
economic, social, cultural, or political well-being of the other” (Ledingham, 2003, p. 184).
Knowing the importance of the relationship between an organization and its publics allows
communicators to manage their messages strategically. Many researchers have defined this
theory and explained how it is used in different situations. “Organization-public relationship
theory works to create and manage a mutually beneficial relationship that takes the common
interest and goals of the organization and public(s) and uses effective communication tools to
better the organization and create a mutual understanding” (Cutlip, Center, & Broom, 1994;
Ledingham, 2003; Maxwell & Carboni, 2014). “Organization-Public Relationship theory shows
that by leveraging and making the most use of an organization’s relationship with its publics, it
can be a key tool for the organization to reach its goals and be prosperous. By taking the time
to build the relationship, the strength between the organization and key stakeholders will
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create a more profitable and enjoyable environment” (Dozier, Grunig, & Grunig, 1995;
Ledingham & Bruning, 1998; Ledingham, 2003).
Building a better relationship and maintaining and managing it is extremely important
for a distrusted organizational entity such as the pharmaceutical industry. While public
relationship management theory is excellent for understanding what a relationship is and how
to manage it strategically, the next step is to know how to measure it to see where the
relationship stands. To address this, Hon and Grunig created guidelines for measuring
relationships in public relations. To evaluate how individuals view an organization there has to
be a way of measuring to see where the organization needs to put more focus and attention to
further the short and long term outcomes of the relationship. Hon and Grunig state that the
way to measure an organization’s relationship with key publics and stakeholders is by focusing
on six elements of the relationship. The six elements mentioned are control mutuality, trust,
satisfaction, commitment, exchange relationship, and communal relationship (Hon & Grunig,
1999). These elements can then be used in a questionnaire that is strong enough to measure
the relationship.
To thoroughly evaluate each variable Hon and Grunig defined them. Control mutuality
is, “as the name suggests, the amount of power or control each party has over the other. While
there should be some natural control balance, stable relationships require both parties each
have some give and take” (Hon & Grunig, 1999). Trust is, “the level of confidence that the
organization and the public have with one another. It is also the level to which the other
organization feels comfortable to completely open up to the other. To measure trust, one has
to look at the ‘underlying dimensions’” (Grunig, 2002). Those dimensions are integrity,
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dependability, and competence. If there is a sole purpose to measure trust, each of those
factors can be measured separately. Satisfaction is, “the how much each party feels the other
is reaching their goals and expectations in a proper way. A satisfying relationship is one where
the benefits outweigh the costs” (Hon & Grunig, 1999). Commitment is, “how much time and
energy each party is willing to put into the relationship to maintain it and help it grown. There
are two dimensions of commitment, which are continuance commitment, refering to a certain
line of action, and affective commitment, which is an emotional orientation” (Hon & Grunig,
1999). An exchange relationship is, “when one party gives benefits to the other only because
the other has provided benefits in the past or is expected to do so in the future” (Hon & Grunig,
1999). The last variable measured is a communal relationship, which is, “when both parties
provide benefits to the other because they are concerned for the welfare of the other -- even
when they get nothing in return. For most public relations activities, developing communal
relationships with key constituencies is much more important to achieve than would be
developing exchange relationships” (Hon & Grunig, 1999). These six variables have been
thoroughly tested and are used as a reliable scale when measuring relationships between an
organizational entity and its stakeholders.

Situational Crisis Communication Theory
Situational Crisis Communication Theory (SCCT), can be used as a framework for postcrisis strategic messaging to maximize reputational protection (Coombs, 2007). This framework
allows practitioners of crisis communication to use these crisis response strategies to protect
their organizations and build a better relationship with their publics and stakeholders. Situational
9

crisis communication theory is rooted in Attribution theory, which “posits that people search for
the causes of events (make attributions), especially those that are negative and unexpected
(Weiner, 1985; Weiner 1986, 2006). Attribution Theory “provides the rationale for the
relationship between many of the variables used in SCCT” (Coombs, 2007).
Variables that are integral to SCCT include attribution of crisis responsibility, crisis history,
and prior relationship reputation. According to SCCT, if stakeholders attribute a greater crisis
responsibility to the organization, their perception of the organization’s reputation will decline;
showing a negative relationship (Coombs and Holladay, 1996, 2001). If there is prior crisis history
for the organization and a negative relationship reputation, then it will increase the reputational
threat. Based off of how each variable is seen in the case, the crisis can then be categorized into
a specific crisis type. If the organization is also a victim of the crisis and there is weak attribution
of crisis responsibility a little to no history, then it is in the victim cluster. If the organizational
actions leading to the crisis were unintentional and has minimal attributions of crisis
responsibility, then it is in the accidental cluster. If the organization knowingly places people at
risk or took inappropriate actions or violet a law/regulation and has strong attributions of crisis
responsibility paired with a string crisis history, then it is in the preventable cluster. (Coombs,
2007). Knowing which cluster the crisis that is being dealt with fits into, a crisis response strategy
can be selected. “Crisis response strategies are used to repair the reputation, to reduce negative
affect, and to prevent negative behavioral intentions. This has been studied extensively in
management and communication (eg,Bradford and Garrett, 1995; Marcus and Goodman, 1991;
Coombs, 2007; Siomkos and Shrivasta, 1993; Allen and Caillouet, 1994; Benoit, 1995). Based on
the previous factors, the pharmaceutical industry can currently be seen in the preventable cluster
10

since they have a strong attribution of crisis responsibility, a crisis history, and the industry has
knowingly placed people at risk and violated laws and regulations.
Situational crisis communication theory also shares beliefs with Image Restoration Theory
in that the ways we communicate can be very powerful (Benoit, 1995). “Image Restoration
Theory offers no conceptual links between the crisis response strategies and elements of the
crisis situation. The SCCT draws upon the crisis response strategies articulated in Image
Restoration Theory by integrating those strategies into a system that predicts how stakeholders
should react to the crisis and the crisis response strategies used to manage the crisis” (Coombs,
2007).
There are three primary crisis response strategies. These include denial, diminish, and
rebuild. The first strategy of denial is defined by Coombs as, “a strategy that seeks to establish a
crisis frame. Deny strategies attempt to remove any connection between the organization and
the crisis. In rumor and challenge crises, managers need to argue that there is no ‘real’ crisis.
Managers deny the truth to the rumor or refute the charges of immoral conduct. If stakeholders,
including the news media, accept the no crisis frame of denial, the organization is spared any
reputational harm” (Coombs, 2007). The type of strategies that can be used to express denial
would be to attack the accuser, deny that there is a crisis, or use a scapegoat.
The second primary strategy is diminish. “The diminish crisis response strategies argue
that a crisis is not as bad as people think or that the organization lacked control over the crisis.
Diminish strategies are most effective when reinforcing existing crisis frames” (Coombs, 2007).
Two strategies for implanting the diminish response are using an excuse to minimize the
organizations responsibility and justification to minimize the perceived damage.
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The third primary response is the rebuild response strategy, which “should be used for
crises with strong attributions of crisis responsibility (preventable crises) regardless of history or
prior relationship reputation” (Coombs, 2007). Types of rebuild crisis response strategies are
compensation, where the crisis manager offers money or other gifts to victims, and/or apology,
where the crisis manager indicates the organization takes full responsibility for the crisis and asks
stakeholders for forgiveness (Coombs, 2007). The SCCT variables crisis history, prior relationship
reputation, and attributed crisis responsibility will determine which cluster the crisis will fall
under. After that the best response strategy will be selected based on perceptions of accepting
outcomes.
For this study, the industry is facing a preventable crisis due to the long prior history, a
negative relationship reputation, and a high attributed crisis responsibility. As mentioned before
this is due to the fact that there have been deaths, distrust, and lawsuits in relation with opioid
companies and the ‘opioid’ crisis. Based on Coombs framework, the rebuild crisis strategy should
yield the best end result relationship for the industry and their publics.

Research Hypothesis
H1: Crisis response message strategies for the pharmaceutical industry will influence and effect
relational outcomes.
P1.1: Rebuild strategy will produce higher levels of trust in publics of the pharmaceutical
industry than denial or silence.
P1.2: Rebuild strategy will produce higher levels of control mutuality in publics of the
pharmaceutical industry than denial or silence.
12

P1.3: Rebuild strategy will produce higher levels of satisfaction in publics of the
pharmaceutical industry than denial or silence.
P1.4: Rebuild strategy will produce higher levels of commitment in publics of the
pharmaceutical industry than denial or silence.
P1.5: Rebuild strategy will produce a stronger communal relationship in publics of the
pharmaceutical industry than denial or silence.
P1.6: Rebuild strategy will produce a stronger exchange relationship in publics of the
pharmaceutical industry than denial or silence.
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CHAPTER THREE
METHODOLOGY

This chapter explains the methodology that was used in this study. It will discuss the
type of research chosen, how it was designed, the procedures used, the instrumentation used
to measure the variables of interest, and the data analysis procedures used. This study employs
a 3 x 1 + control post-test only experimental design based on crisis response strategies and
measuring relationships. The crisis response strategies used will be rebuild, deny, and silence.
The relationship variables measured will be trust, control mutuality, commitment, satisfaction,
exchange relationships, and communal relationships.

Context of Study
To test the SCCT crisis response strategies and see is rebuild, denial, or silence strategies
yield the strongest relationship with the pharmaceutical industry an experiment is needed. The
type of crisis chosen for this experiment was a preventable one. Many of the cases that have
been highlighted in the media about the pharmaceutical industry are those that are court cases
where the industry is at fault and, therefore, must pay settlements. With other factors coming
into play, based on the SCCT framework, such as attributed responsibility and crisis history,
using a preventable crisis will replicate the current real industry environment. There will be four
conditions with two manipulated variables, an experimental control, and a true control
14

conducted. Each condition is further explained in the instrumentation section. The variables
used to measure the relationship between the respondents, and the organization will be a 5
point Likert-scale.

Study Respondents
The sample population used for this study was 125 millennials with different
backgrounds. They varied in age, gender, race, and geographical location. The importance of
conducting this study with the younger and upcoming generation is to see how they feel their
relationship is with the pharmaceutical industry after being exposed to a preventable crisis and
seeing a response. This generation of millennials will be the future people who may make
deciding factors on the industry itself.

Procedures
The study received USF IRB approval prior to launching. After approval was obtained,
participants who fit the millennia criteria were recruited through social media channels to
participate in the study. The recruitment method used was a social media advertisement
located in Appendix A.
With this study using the pharmaceutical industry, some of the respondents may
already have prejudgments towards a particular company, within the industry. Knowing this
and to decrees, possible bias, the study will focus on the industry as a whole. While the
scenarios that are used to simulate the preventable crisis will be based on a real
pharmaceutical crisis the name of pharmaceutical companies will not be noted.
15

Once participants selected the link to participate, they were able to read more about
the study and were asked to read an informed consent statement and select that they agreed
to participate before moving forward. As stated before, there were four conditions. The
conditions were given in a randomized order through the USF Qualtrics system. The first one
featured the cover of a newspaper with a paragraph describing the court case trial involving the
pharmaceutical industry. The court case was based on the recent Johnson & Johnson opioid
case, which established credibility by using a real-world case. The newspaper article is based
with a quote from a CBS news article published on August 27th of 2019 (CBS News, 2019). On
the next page of the newspaper article an advertisement was taken out by PhRMA, a board of
pharmaceutical CEO’s, with a quote from the Chairman of the board responding to the crisis
using the rebuilding strategies of compensation an apology. The second condition has the same
newspaper article describing the crisis situation, but the advertisement on the next page has
the Chairman using denial response strategies. The denial response is the exact response that
Johnson & Johnson gave after the exact case that is mentioned in the fake newspaper. The third
condition, and the experimental control, will use the same newspaper article describing the
situation but will have no response from the Chairman of PhRMA, which will test silence.
Silence is different than testing no response because choosing to stay silent is for a strategic
and thought out purpose. The last condition and the true control will only be the relationship
questionnaire of the industry, which will test for the population’s feelings without a stimulus
and will serve as the baseline of this study.
After the newspaper and advertisement are given, respondents received a
questionnaire to measure their relationship with the industry. The questionnaire was derived
16

from Hon and Grunig (1999) guidelines for measuring relationships. The variables that were
measured were trust, control mutuality, commitment, exchange relationship, and communal
relationship. The questionnaire was measured with a 5-point scale on how much the responded
agreed or disagreed with each statement in relation to their relationship. This scale has been
tested during a pre-test of the study for validity and reliability and is strong enough to be used
in the context of measuring relationships.
After the participants filled out their responses and answer unidentifiable demographic
information they were shown a debriefing statement that informed them about the nature of
the study and enforced that what they read was manipulated for the study. They then had the
opportunity to withdraw all of their responses if they felt they wanted to. All versions of the
questionnaire can be found in Appendix B, C, D, and E.

Instrumentation
The following statements have been derived from Hon and Grunig’s guidelines for
measuring a relationship. Each statement below has been adapted from their work (Grunig &
Hon, 1999).
“Trust will be measured with the following statements:
1) The pharmaceutical industry treats people like me fairly and justly.
2) Whenever the pharmaceutical industry makes an important decision, I know it will be
concerned about people like me.
3) The pharmaceutical industry can be relied on to keep its promises.
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4) I believe that the pharmaceutical industry takes the opinions of people like me into account
when making decisions.
5) I feel very confident about the pharmaceutical industry’s skills.
6) The pharmaceutical industry has the ability to accomplish what it says it will do.
Control Mutuality will be measured with the following statements:
1) The pharmaceutical industry and people like me are attentive to what each other say.
2) The pharmaceutical industry believes the opinions of people like me are legitimate.
3) In dealing with people like me, the pharmaceutical industry has a tendency to throw its
weight around.
4) The pharmaceutical industry really listens to what people like me have to say.
5) The management of the pharmaceutical industry gives people like me enough say in the
decision-making process.
Commitment will be measured with the following statements:
1) I feel that the pharmaceutical industry is trying to maintain a long-term commitment to
people like me.
2) I can see that the pharmaceutical industry wants to maintain a relationship with people like
me.
3) There is a long-lasting bond between the pharmaceutical industry and people like me.
4) Compared to other industries, I value my relationship with the pharmaceutical industry
more.
5) I would rather work together with this industry than not.
Satisfaction will be measured with the following statements:
18

1) I am happy with this industry.
2) Both the industry and people like me benefit from the relationship.
3) Most people like me are happy in their interactions with this industry.
4) Generally speaking, I am pleased with the relationship this industry has established with
people like me.
5) Most people enjoy dealing with this industry.
Exchange relationships will be measured by the following statements:
1) Whenever this industry gives or offers something to people like me, it generally expects
something in return.
2) Even though people like me have had a relationship with this industry for a long time, it still
expects something in return whenever it offers us a favor.
3) This industry will compromise with people like me when it knows that it will gain something.
4) This industry takes care of people who are likely to reward the industry.
Finally, communal relationships with me measured by the following statements:
1) This industry does not especially enjoy giving others aid.
2) This industry is very concerned about the welfare of people like me.
3) I feel that this industry takes advantage of people who are vulnerable.
4) I think that this industry succeeds by stepping on other people.
5) This industry helps people like me without expecting anything in return” (Grunig & Hon,
1999).
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Manipulation Check
To ensure that the manipulated variables are correctly being used, a manipulation check
will be added to the questionnaire. To test the response strategies three original questions
were added about the denial strategy and the rebuild strategy. Based on the definition on the
denial strategy, these three statements will be measured on the same scale as the rest of the
questionnaire and were tested during a pre-test of the study:
1) The industry attempted to remove connection between the themselves and the crisis.
2) The industry argued that there was no ‘real’ crisis.
3) The industry denied the truth to the crisis and refuted the charges of immoral conduct.
Based on the definition of rebuild strategy, these three original statements will be
measured as well:
1) The industry offered material and/or symbolic forms of aid to victims.
2) The industry offered compensation or a full apology.
3) The industry said and did things to benefit stakeholders.

Data Collection
Once the data was collected through Qualtrics, SPSS was for the statistical analysis of
the data. A One-Way ANOVA was used to check validity and reliability. It was also used to
compare each of the relational variables with the crisis messaging strategies.
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CHAPTER FOUR
RESULTS

This study set out with the intention to test and expand on the organization-public
relationship theory by Hon and Grunig and see how it upheld when combined with situational
crisis communication message strategies from Coombs within the scope of the Pharmaceutical
Industry. The variables that makeup a relationship were tested with hypothesis in mind that
there would be effected by the separate crisis communication message strategies of denial,
rebuild, and silence. The results section will show the findings of this study and will show who
the participants were. It will go over the manipulation check, the reliabilities, descriptive
statistics, and hypotheses results.

Demographics
Table 1 shows results of the demographics of respondents by sex, race, and age. Based
on the data collected, the respondents were predominantly female (n=91) of the 125
participants. They were also mostly Caucasian (n=108) with Hispanic (n=6) and Other ethnicities
(n=6) as the second majority. Most respondents were between the ages of 24 – 27 (n=73) but
all still fall in the age range of a millennial.
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Table 1. Demographic profile of study respondents.
What is your sex?
Valid

Female
Male
Other
Total

Total
What is your ethnicity?

Frequency
91
33
1
125
125

Percent
72.8
26.4
.8
100.0
100.0

Frequency
Valid

Total

Hispanic
African American
Caucasian
Asian
Other
Total

6
1
108
4
6
125
125

Percent
4.8
.8
86.4
3.2
4.8
100.
100.0

What is your age? (please enter a whole number in years)
Frequency
Percent
Valid
23
9
7.2
24
19
15.2
25
25
20
26
13
10.4
27
16
12.8
28
7
5.6
29
7
5.6
30
6
4.8
31
2
1.6
32
2
1.6
33
2
1.6
34
2
1.6
35
4
3.2
36
3
2.4
37
3
2.4
22

Table 1 (Continued)
38
39
40
Total

2
1
2
125

1.6
.8
1.6
100.0

Manipulation Checks
Once demographic information was analyzed to understand who the participants were,
the manipulation checks were analyzed for reliability and significance. Based on the below data
in Table 2 and Table 3, both the items used to measure the manipulations showed no internal
consistency so they were analyzed separately. The manipulation check questions were original
items and may be the reason for the lack of reliability in this study.
Table 2. Manipulation Check – Denial.
Reliability Statistics
Cronbach's
Alpha
N of Items
.611
3

Item Statistics
MCD-The pharmaceutical industry argued that there was no
‘real’ crisis.
MCD-The pharmaceutical industry attempted to remove the
connection between themselves and the crisis.
MCD-The pharmaceutical industry denied the truth to the crisis
and refuted the charges of immoral conduct.

Mean Std. Deviation
3.46
1.241
3.64

1.253

125

3.78

1.013

125

Item-Total Statistics
Scale
Scale
Cronbach's
Mean if Variance Corrected
Alpha if
Item
if Item Item-Total
Item
Deleted Deleted Correlation Deleted
23

N
125

Table 2 (Continued)
MCD-The pharmaceutical industry argued
that there was no ‘real’ crisis.
MCD-The pharmaceutical industry
attempted to remove the connection
between themselves and the crisis.
MCD-The pharmaceutical industry denied
the truth to the crisis and refuted the
charges of immoral conduct.

7.42

3.585

.394

.551

7.24

3.555

.392

.556

7.10

3.975

.490

.434

Table 3. Manipulation Check – Rebuild.
Reliability Statistics
Cronbach's
Alpha
N of Items
.055
3
Item Statistics
MCR-The pharmaceutical industry said and did things to
benefit stakeholders.
MCR-The pharmaceutical industry offered compensation
or a full apology.
MCR-The pharmaceutical industry offered material and/or
symbolic forms of aid to victims.

Mean Std. Deviation
4.26
.888

N
125

2.26

.968

125

2.86

.995

125

Item-Total Statistics

MCR-The pharmaceutical industry said
and did things to benefit stakeholders.
MCR-The pharmaceutical industry
offered compensation or a full apology.
MCR-The pharmaceutical industry
offered material and/or symbolic forms
of aid to victims.

Scale
Scale
Cronbach's
Mean if Variance if Corrected
Alpha if
Item
Item
Item-Total
Item
Deleted
Deleted Correlation Deleted
5.13
2.661
-.218
.551
7.12

1.477

.172

-.407a

6.52

1.397

.184

-.472a
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a. The value is negative due to a negative average covariance among items. This violates
reliability model assumptions. You may want to check item codings.
After the reliability was determined for both manipulation checks, a One-Way ANOVA
was conducted. As a result, the One-Way ANOVA was adjusted to look at differences in
treatments individually. While there were individual significances of less than .05 in some
treatments it did not work in the hypothesized way, as seen in table 4. Future research may
look at adapting these original questions that did show significance and elaborating on them.
Table 4. Manipulation Check – One-Way ANOVA.
Descriptives

MCD-The pharmaceutical
industry argued that there
was no ‘real’ crisis.

CONTROL-BRAND ONLY
ARTICLE+DENIAL
ARTICLE+APOLOGY
ARTICLE+SILENCE
Total
MCR-The pharmaceutical
CONTROL-BRAND ONLY
industry said and did things ARTICLE+DENIAL
to benefit stakeholders.
ARTICLE+APOLOGY
ARTICLE+SILENCE
Total
MCD-The pharmaceutical
CONTROL-BRAND ONLY
industry attempted to
ARTICLE+DENIAL
remove the connection
ARTICLE+APOLOGY
between themselves and the ARTICLE+SILENCE
crisis.
Total
MCR-The pharmaceutical
CONTROL-BRAND ONLY
industry offered
ARTICLE+DENIAL
compensation or a full
ARTICLE+APOLOGY
apology.
ARTICLE+SILENCE
Total
CONTROL-BRAND ONLY
25

N
49
54
44
42
189
49
54
44
42
189
33
46
40
33
152
33
46
40
33
152
27

Mean
2.98
3.39
3.36
3.93
3.40
4.08
4.26
4.11
4.43
4.22
3.36
3.67
3.50
4.09
3.65
2.52
2.39
2.17
1.88
2.25
3.04

Std.
Std.
Deviation Error
1.031 .147
1.156 .157
1.432 .216
.947 .146
1.192 .087
.909 .130
.828 .113
.945 .143
.859 .133
.888 .065
1.141 .199
1.012 .149
1.359 .215
1.208 .210
1.197 .097
.870 .152
.881 .130
1.083 .171
.992 .173
.978 .079
1.126 .217

Table 4 (Continued)
MCR-The pharmaceutical
industry offered material
and/or symbolic forms of aid
to victims.
MCD-The pharmaceutical
industry denied the truth to
the crisis and refuted the
charges of immoral conduct.

ARTICLE+DENIAL
ARTICLE+APOLOGY
ARTICLE+SILENCE
Total

37
33
28
125

2.70
2.91
2.86
2.86

.996
.980
.891
.995

.164
.171
.168
.089

CONTROL-BRAND ONLY
ARTICLE+DENIAL
ARTICLE+APOLOGY
ARTICLE+SILENCE
Total

27
37
33
28
125

3.04
3.81
3.91
4.32
3.78

.854
.811
1.156
.819
1.013

.164
.133
.201
.155
.091

Mean
Square
6.819
1.334

F
5.112

Sig.
.002

1.115
.782

1.425

.237

ANOVA

MCD-The pharmaceutical Between Groups
industry argued that there Within Groups
was no ‘real’ crisis.
Total
MCR-The pharmaceutical Between Groups
industry said and did
Within Groups
things to benefit
Total
stakeholders.
MCD-The pharmaceutical Between Groups
industry attempted to
Within Groups
remove the connection
Total
between themselves and
the crisis.
MCR-The pharmaceutical Between Groups
industry offered
Within Groups
compensation or a full
Total
apology.
MCR-The pharmaceutical Between Groups
industry offered material Within Groups
and/or symbolic forms of Total
aid to victims.
MCD-The pharmaceutical Between Groups
industry denied the truth Within Groups

26

Sum of
Squares
20.458
246.780
267.238
3.344
144.761
148.106

3
185
188
3
185
188

10.047
206.472
216.520

3
148
151

3.349
1.395

2.401

.070

8.011
136.489
144.500

3
148
151

2.670
.922

2.896

.037

1.839
120.849
122.688

3
121
124

.613
.999

.614

.607

23.695
103.473

3
121

7.898
.855

9.236

.000

df

Table 4 (Continued)
to the crisis and refuted
the charges of immoral
conduct.

Total

127.168

124

Relational Reliabilities
After the manipulation checks resulted in a different manner than hypothesized, each
individual relational variable was tested for reliability. Trust (a=.771) can be found in table 5,
commitment (a=.705) in table 6, satisfaction (a=.783) in table 7, and control mutuality (a=.733)
in table 8.
Table 5. Trust – Reliability
Reliability Statistics
Cronbach's
Alpha
N of Items
.771
6

Item Statistics
Trust_I believe that this
pharmaceutical industry
takes the opinions of
people like me into
account when making
decisions.
Trust_The
pharmaceutical industry
treats people like me
fairly and justly.
Trust_The
pharmaceutical industry
has the ability to
accomplish what it says it
will do.

Mean
Std. Deviation
1.97
1.085

N
125

2.13

.907

125

3.98

1.107

125
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Table 5 (Continued)
Trust_Whenever the
pharmaceutical industry
makes an important
decision, I know it will be
concerned about people
like me.
Trust_The
pharmaceutical industry
can be relied on to keep
its promises.
Trust_I feel very
confident about the
pharmaceutical
industry’s skills.

1.96

1.035

125

1.94

.936

125

3.06

1.297

125

Item-Total Statistics

Trust_I believe that this
pharmaceutical industry
takes the opinions of
people like me into
account when making
decisions.
Trust_The
pharmaceutical industry
treats people like me
fairly and justly.
Trust_The
pharmaceutical industry
has the ability to
accomplish what it says it
will do.

Scale Variance
Scale Mean if
if Item
Item Deleted
Deleted
13.07
14.164

Corrected
Cronbach's
Item-Total
Alpha if Item
Correlation
Deleted
.471
.749

12.91

14.145

.618

.717

11.06

15.537

.277

.797
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Table 5 (Continued)
Trust_Whenever the
pharmaceutical industry
makes an important
decision, I know it will be
concerned about people
like me.
Trust_The
pharmaceutical industry
can be relied on to keep
its promises.
Trust_I feel very
confident about the
pharmaceutical
industry’s skills.

13.08

13.026

.681

.695

13.10

14.087

.601

.720

11.98

12.629

.529

.738

Table 6. Commitment – Reliability
Based on the reliability acceptable Cronbach’s Alpha the number of items was dropped to the
remaining four alphas.
Reliability Statistics
Cronbach's
Alpha
N of Items
.705
4

Item Statistics
Committment_Compare
d to other industries, I
value my relationship
with the pharmaceutical
industry more.
Committment_I can see
that the pharmaceutical
industry wants to
maintain a relationship
with people like me.

Mean
Std. Deviation
2.05
1.156

2.87

1.314
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N
125

125

Table 6 (Continued)
Committment_I feel that
the pharmaceutical
industry is trying to
maintain a long-term
commitment to people
like me.
Committment_I would
rather work together
with the pharmaceutical
industry than not.
Committment_There is a
long-lasting bond
between the
pharmaceutical industry
and people like me.

2.67

1.183

125

3.50

1.261

125

2.49

1.248

125

Item-Total Statistics

Commitment Compared
to other industries, I
value my relationship
with the pharmaceutical
industry more.
Commitment can see
that the pharmaceutical
industry wants to
maintain a relationship
with people like me.
Commitment feel that
the pharmaceutical
industry is trying to
maintain a long-term
commitment to people
like me.

Scale Variance
Scale Mean if
if Item
Item Deleted
Deleted
11.53
11.929

Corrected
Cronbach's
Item-Total
Alpha if Item
Correlation
Deleted
.440
.632

10.70

10.984

.467

.619

10.90

11.233

.523

.596
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Table 6 (Continued)
Commitment would
rather work together
with the pharmaceutical
industry than not.
Commitment There is a
long-lasting bond
between the
pharmaceutical industry
and people like me.

10.08

12.784

.267

.705

11.09

11.016

.507

.601

Table 7. Satisfaction – Reliability
Reliability Statistics
Cronbach's
Alpha
N of Items
.783
5

Item Statistics
Satisfaction_I am happy
with the pharmaceutical
industry.
Satisfaction_Generally
speaking, I am pleased
with the relationship the
pharmaceutical industry
has established with
people like me.
Satisfaction_Both the
pharmaceutical industry
and people like me
benefit from the
relationship.
Satisfaction_Most people
enjoy dealing with the
pharmaceutical industry.

Mean
Std. Deviation
2.15
1.108

N
125

1.98

1.032

125

2.86

1.266

125

1.69

.865

125
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Table 7 (Continued)
Satisfaction_Most people
like me are happy in their
interactions with the
pharmaceutical industry.

2.37

1.133

125

Item-Total Statistics

Satisfaction_I am happy
with the pharmaceutical
industry.
Satisfaction_Generally
speaking, I am pleased
with the relationship the
pharmaceutical industry
has established with
people like me.
Satisfaction_Both the
pharmaceutical industry
and people like me
benefit from the
relationship.
Satisfaction_Most people
enjoy dealing with the
pharmaceutical industry.
Satisfaction_Most people
like me are happy in their
interactions with the
pharmaceutical industry.

Scale Variance
Scale Mean if
if Item
Item Deleted
Deleted
8.90
9.926

Corrected
Cronbach's
Item-Total
Alpha if Item
Correlation
Deleted
.672
.702

9.07

10.503

.640

.716

8.19

10.334

.480

.776

9.37

12.283

.464

.771

8.69

10.410

.568

.739

Table 8. Control Mutuality – Reliability
Based on the reliability acceptable Cronbach’s Alpha the number of items was dropped to the
remaining four alphas.
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Table 8 (Continued)
Reliability Statistics
Cronbach's
Alpha
N of Items
.733
4

Item Statistics
Control_The
pharmaceutical industry
really listens to what
people like me have to
say.
Control_The
management of the
pharmaceutical industry
gives people like me
enough say in the
decision-making process.
ControlR_In dealing with
people like me, the
pharmaceutical industry
has a tendency to throw
its weight around.
Control_The
pharmaceutical industry
believes the opinions of
people like me are
legitimate.
Control_The
pharmaceutical industry
and people like me are
attentive to what each
other say.

Mean
Std. Deviation
1.75
.956

N
125

1.70

.959

125

4.04

.797

125

2.33

1.091

125

2.42

1.123

125
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Item-Total Statistics

Control_The
pharmaceutical industry
really listens to what
people like me have to
say.
Control_The
management of the
pharmaceutical industry
gives people like me
enough say in the
decision-making process.
ControlR_In dealing with
people like me, the
pharmaceutical industry
has a tendency to throw
its weight around.
Control_The
pharmaceutical industry
believes the opinions of
people like me are
legitimate.
Control_The
pharmaceutical industry
and people like me are
attentive to what each
other say.

Scale Variance
Scale Mean if
if Item
Item Deleted
Deleted
10.49
5.478

Corrected
Cronbach's
Item-Total
Alpha if Item
Correlation
Deleted
.512
.358

10.54

5.428

.523

.351

8.20

9.516

-.298

.733

9.91

5.145

.475

.367

9.82

5.404

.387

.431

Hypotheses
After seeing that all of the individual relational variables were reliable, the data was
tested for the hypotheses. First, a set of descriptive statistics were collapsed to test and
compare mean scores. Trust, commitment, control mutuality, and satisfaction all produced
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means less than an average of 3 of out the 5 point scale. The data also showed aspects of both
exchange and communal relationships.
Table 9. Hypotheses Descriptives
Descriptive Statistics
N
Trust
COMMITMENT2
CM2
Satisfaction
Exchange2
COMMUNal2
Valid N (listwise)

125
125
125
125
152
125
125

Minimum
1.00
1.00
1.00
1.00
1.50
3.00

Maximum
4.17
4.75
4.20
4.00
5.00
5.00

Mean
2.5067
2.5200
2.1056
2.2112
3.9671
4.4000

Std. Deviation
.72999
.89386
.79700
.79608
.84898
.61892

Descriptives

Trust

Satisfaction

COMMITMENT2

CM2

N
27
37
33
28
125
27
37
33
28
125
27
37
33
28
125
27
37
33
28

CONTROL-BRAND ONLY
ARTICLE+DENIAL
ARTICLE+APOLOGY
ARTICLE+SILENCE
Total
CONTROL-BRAND ONLY
ARTICLE+DENIAL
ARTICLE+APOLOGY
ARTICLE+SILENCE
Total
CONTROL-BRAND ONLY
ARTICLE+DENIAL
ARTICLE+APOLOGY
ARTICLE+SILENCE
Total
CONTROL-BRAND ONLY
ARTICLE+DENIAL
ARTICLE+APOLOGY
ARTICLE+SILENCE
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Mean
2.6975
2.5495
2.4293
2.3571
2.5067
2.3333
2.3081
2.2909
1.8714
2.2112
2.4815
2.4865
2.6364
2.4643
2.5200
2.3556
2.1568
2.0727
1.8357

Std.
Deviation
.63387
.72421
.78950
.74358
.72999
.75447
.78258
.87191
.69966
.79608
.82312
.83945
.94185
1.00165
.89386
.63811
.92272
.73624
.77756

Std. Error
.12199
.11906
.13743
.14052
.06529
.14520
.12866
.15178
.13222
.07120
.15841
.13800
.16395
.18929
.07995
.12280
.15169
.12816
.14695

Table 9 (Continued)
Exchange2

COMMUNal2

Total
CONTROL-BRAND ONLY
ARTICLE+DENIAL
ARTICLE+APOLOGY
ARTICLE+SILENCE
Total
CONTROL-BRAND ONLY
ARTICLE+DENIAL
ARTICLE+APOLOGY
ARTICLE+SILENCE
Total

125
33
46
40
33
152
27
37
33
28
125

2.1056
3.9697
3.9674
4.0000
3.9242
3.9671
4.2222
4.4595
4.3939
4.5000
4.4000

.79700
.84723
.76305
.83972
1.00095
.84898
.65535
.61665
.67033
.50918
.61892

.07129
.14748
.11251
.13277
.17424
.06886
.12612
.10138
.11669
.09623
.05536

An ANOVA was then conducted to accept or reject the studies hypotheses. Based on the
data in table 10 and no significance below .05 the ANOVA can conclude that there was no
significant difference between message groups.
Table 10. Hypotheses – ANOVA
ANOVA

Trust

Satisfaction

COMMITMENT2

CM2

Exchange2

Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total
Between Groups
Within Groups
Total

Sum of
Squares
1.875
64.203
66.078
4.192
74.392
78.584
.615
98.460
99.075
3.859
74.907
78.766
.104
108.731
108.836
36

df
3
121
124
3
121
124
3
121
124
3
121
124
3
148
151

Mean
Square
.625
.531

F
1.178

Sig.
.321

1.397
.615

2.273

.084

.205
.814

.252

.860

1.286
.619

2.078

.107

.035
.735

.047

.986

Table 10 (Continued)
COMMUNal2
Between Groups
Within Groups
Total

1.265
46.235
47.500
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3
121
124

.422
.382

1.104

.350

CHAPTER FIVE
DISCUSSION

While the overall hypotheses of this study did not show that the message strategies
would have an effect on millennials relationship with the pharmaceutical industry the data does
show other important information. It shows how millennials feel about the industry in different
relational aspects, its shows how deep rooted relationships are, and it shows the strong
foundation of organization-public relationship theory.
As discussed in the background of this study, millennials are a generation that tend to
be invested in different forms of media. Many of these media platforms provide this generation
and others with news, articles, and other forms of information that help people shape their
feelings and relationships with organizations. For the millennial generation who may not have
direct contact with the pharmaceutical industry this may be their only resource for shaping
their relationships. Knowing this information and looking at the data and means from table 9
show that no matter what message the respondents were exposed to they had an overall less
strong relationship in each of the core relationship variables. While the manipulation check
showed that the denial and apology tactics did not translate when the study was transferred to
an online format the data was then able to show that this populations relationships may be too
deep rooted to be effected by one message. While the data also showed that there were

38

aspects of both a communal and exchange relationship the pharmaceutical industry should aim
to strengthen the communal relationship with this demographic.
While the crisis message strategies produced by Coombs did not take effect in this
study to change relationships, Hon and Grunig’s organization-public relationship theory was
upheld. The descriptive data was collapsed into variables for the hypothesis test and composite
mean scores. A series of ANOVAS also determined that there was no significance in terms of the
crisis messaging strategies. However, each relational variable that was produced by Hon and
Grunig yielded reliable results with Cronbach alpha’s all above .7. While this study was unable
to expand on the theory it was able to reinforce the variables that make up a relationship and
are used to measure one. This theory is mostly seen in practice for individual organizations and
in fields other than pharmaceuticals. Testing this theory in a new area and with an industry as a
whole shows that these principles for measuring a relationship are sound.
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CHAPTER SIX
CONCLUSION

In conclusion, if the pharmaceutical industry sees the importance in having the
millennial generation as a key stakeholder the industry will have to work hard to change their
current relationship with them. Many studies have not been done to look at the millennial
generation and organizations such as the pharmaceutical industry. While this study did not
show that different crisis message strategies could help build a stronger relationship between
the two groups it showed just how negatively millennials see their relationship with the
industry and that those beliefs are deeply rooted. With millennials being the next generation to
create change for this industry it is vital that the industry focuses their attention on millennials
and begins to build better and stronger relationships.

Limitations
This study was conducted during the 2020 Coronavirus pandemic. This caused what was
supposed to be an experiment designed to be conducted in person for full effect to be moved
into an online format. The original study had to not only be changed to fit an online Qualtrics
format, but the target population had to change as well to a group that would be reachable
during the pandemic virtually. Another limitation was that the questionnaire had to be shared
on social media. This is a limitation because while it was being shared the questionnaire was
40

cyber attacked by a bot that caused blank results to be entered into the system. Once those
blank answers were removed a smaller sample size than desired was left to work with. Another
limitation was the use of original manipulation check questions. While they held up during the
pre-test that was conducted, they did not manipulate the messages in the way they were
supposed to for this study.

Areas for Further Research
Future research on this topic is needed for expanding the theory and field of mass
communication but also for insights into an industry and population that has not been
compared before. Research could also continue in the qualitative field by looking at all aspects
of a relationship with other populations such as the elderly or with baby boomers and compare
relationships amongst age groups. Another aspect that could be added to those studies is
looking at cultural and ethnical backgrounds and compare relationships there as well. Research
could also look at how millennials or different groups find their information about the industry
that helps them develop their relationships.
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Appendix B: Relationship Questionnaire - Denial
Thank you for agreeing to participate in this study!
We are interested in your personal opinions regarding your relationship with the
pharmaceutical industry. Please take a few minutes to review the next pages. Next, you will be
presented with a series of statements about your opinions. Please indicate your level of
agreement with each statement by selecting the appropriate response based on the scale
provided, next to each statement.
Please answer as honestly as possible. There are no right or wrong answers. Your responses to
this questionnaire will remain completely anonymous. The questionnaire will take about 10
minutes.
Thank you in advance for participating in this study!
______________________
Informed Consent Statement
You are being asked to take part in a research study. The information in this document should help you to decide if
you would like to participate. This study is being led by Nikoletta Pappas, who is a Graduate student at/in Mass
Communication at the University of South Florida. This person is called the Principal Investigator. She is being
guided in this research by Dr. Kelly Werder. Other approved research staff may act on behalf of the Principal
Investigator. This study is being conducted at Qualtrics and is supported/sponsored by Dr. Kelly Werder. The
purpose of the study is to further research on crisis messaging and its effect on relationships amongst millennials
with the pharmaceutical industry. This research will include a 10-15 minute questionnaire that will be taken on
Qualtrics. You are being asked to take part because you are considered a millennial, being born between 19801996. Your participation is voluntary. You do not have to participate and may stop your participation at any
time. There will be no penalties or loss of benefits or opportunities if you do not participate or decide to stop once
you start. We do not know if you will receive any benefit from your participation. There is no cost to participate.
You will not be compensated for your participation. This research is considered minimal risk. Minimal risk means
that study risks are the same as the risks you face in daily life. Even if we publish the findings from this study, we
will keep your study information private and confidential. Anyone with the authority to look at your records must
keep them confidential.
Millennials are being asked to participate because there is limited research on their relationship with the industry
and it is something that should be looked into, since they will be the future generation to make decisions for the
industry. If you take part in this study, you will be asked to complete a survey online through Qualtrics. The study
will take between 10-15 minutes to complete. All data will be anonymous. You do not have to participate in this
research study. You should only take part in this study if you want to volunteer. You should not feel that there is
any pressure to take part in the study. You are free to participate in this research or withdraw at any time. There
will be no penalty or loss of benefits you are entitled to receive if you stop taking part in this study. You will receive
no benefit from this study. This research is considered to be minimal risk. We will do our best to keep your records
private and confidential. We cannot guarantee absolute confidentiality. Your personal information may be
disclosed if required by law. Certain people may need to see your study records. The only people who will be
allowed to see these records are the principal investigator, research team, advising team, and the USF Institutional
Review Board (IRB). It is possible, although unlikely, that unauthorized individuals could gain access to your
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responses because you are responding online. Confidentiality will be maintained to the degree permitted by the
technology used. No guarantees can be made regarding the interception of data sent via the Internet. However,
your participation in this online survey involves risks similar to a person’s everyday use of the Internet. If you
complete and submit an anonymous survey and later request your data be withdrawn, this may or may not be
possible as the researcher may be unable to extract anonymous data from the database. Your personal
information collected for this research will be kept as long as it is needed to conduct this research. Once your
participation in the research is over, your information will be stored in accordance with applicable policies and
regulations. Your permission to use your personal data will not expire unless you withdraw it in writing. You may
withdraw or take away your permission to use and disclose your information at any time. You do this by sending
written notice to the Principal Investigator at the following address: 8903 Citrus Village Drive, Apt 206, Tampa, FL
33626. While we are conducting the research study, we cannot let you see or copy the research information we
have about you. After the research is completed, you have a right to see the information about you, as allowed by
USF policies. If you have concerns about the use or storage of your personal information, you have a right to lodge
a complaint with the data supervisory authority in your country.
If you have any questions, concerns or complaints about this study, call Nikoletta Pappas at (302)-757-6069. If you
have questions about your rights, complaints, or issues as a person taking part in this study, call the USF IRB at
(813) 974-5638or contact the IRB by email atRSCH-IRB@usf.edu.
We may publish what we learn from this study. If we do, we will not let anyone know your name. We will not
publish anything else that would let people know who you are. You can print a copy of this consent form for your
records. I freely give my consent to take part in this study. I understand that by proceeding with this survey, I am
agreeing to take part in research and I am 18 years of age or older.
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Figure A. Daily Newspaper:
Please read the selected front page of the newspaper.
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Figure B. PhRMA Pubic Statement Denial
Please read the following ad taken out by Pharmaceutical Research and
Manufacturers of America (PhRMA) in the newspaper.
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Instructions: Using the scale below, please indicate your level of agreement with the following
statements by writing the appropriate number in the blank provided.
__1__ __2__ __3__ __4__ __5__
Strongly
Strongly
Disagree
Agree
TRUST
____ 1. This industry treats people like me fairly and justly.
____ 2. Whenever this industry makes an important decision, I know it will be concerned
about people like me.
____ 3. This industry can be relied on to keep its promises.
____ 4. I believe that this industry takes the opinions of people like me into account when
making decisions.
____ 5. I feel very confident about this industry’s skills.
____ 6. This industry has the ability to accomplish what it says it will do.
CONTROL MUTUALITY
____7. This industry and people like me are attentive to what each other say.
____8. This industry believes the opinions of people like me are legitimate.
____9. In dealing with people like me, this industry has a tendency to throw its weight
around.
____10. This industry really listens to what people like me have to say.
____11. The management of this industry gives people like me enough say in the decisionmaking process.
COMMITTMENT
____12. I feel that this industry is trying to maintain a long-term commitment to people like
me.
____13. I can see that this industry wants to maintain a relationship with people like me.
____14. There is a long-lasting bond between this industry and people like me.
____15. Compared to other industries, I value my relationship with this industry more.
____16. I would rather work together with this industry than not.
SATISFACTION
____17. I am happy with this industry.
____18. Both the industry and people like me benefit from the relationship.
____19. Most people like me are happy in their interactions with this industry.
____20. Generally speaking, I am pleased with the relationship this industry has established
with people like me.
____21. Most people enjoy dealing with this industry.
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EXCHANGE RELATIONSHIPS
____22. Whenever this industry gives or offers something to people like me, it generally
expects something in return.
____23. Even though people like me have had a relationship with this industry for a long time,
it still expects something in return whenever it offers us a favor.
____24. This industry will compromise with people like me when it knows that it will gain
something.
____25. This industry takes care of people who are likely to reward the industry.
COMMUNAL RELATIONSHIPS
____26. This industry does not especially enjoy giving others aid.
____27. This industry is very concerned about the welfare of people like me.
____28. I feel that this industry takes advantage of people who are vulnerable.
____29. I think that this industry succeeds by stepping on other people.
____30. This industry helps people like me without expecting anything in return.
DENIAL MANIPULATION CHECK
____31. The industry attempted to remove connection between the themselves and the crisis.
____32. The industry argued that there was no ‘real’ crisis.
____33. The industry denied the truth to the crisis and refuted the charges of immoral
conduct.
REBUILD MANIPULATION CHECK
____34. The industry offered material and/or symbolic forms of aid to victims.
____35. The industry offered compensation or a full apology.
____36. The industry said and did things to benefit stakeholders.
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DEMOGRAPHICS
Instructions: Listed below are a few demographic questions about you that will help us to
understand your answers. Please or select the appropriate response.
48. What is your age? __________
49. What is your sex? ________ Female ________ Male ________Other
50. What is your ethnicity?
c Caucasian

c African-American

c Hispanic

c Pacific Islander

c American Indian

c Asian

c Other
Thank you for your help in better understanding perceptions of your relationship with
the pharmaceutical industry!
This study investigated the effects of different crisis response messages. The scenarios you
were exposed to were created exclusively for this study, are hypothetical, and in no way reflect
the organization. After knowing the true nature of the study, you may choose to withdraw your
answers by selecting “yes” or your responses may be used in the study by selecting “no”. Thank
you again for your time.
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Appendix C: Relationship Questionnaire - Apology
Thank you for agreeing to participate in this study!
We are interested in your personal opinions regarding your relationship with the
pharmaceutical industry. Please take a few minutes to review the next pages. Next, you will be
presented with a series of statements about your opinions. Please indicate your level of
agreement with each statement by selecting the appropriate response based on the scale
provided, next to each statement.
Please answer as honestly as possible. There are no right or wrong answers. Your responses to
this questionnaire will remain completely anonymous. The questionnaire will take about 10
minutes.
Thank you in advance for participating in this study!
______________________
Informed Consent Statement
You are being asked to take part in a research study. The information in this document should help you to decide if
you would like to participate. This study is being led by Nikoletta Pappas, who is a Graduate student at/in Mass
Communication at the University of South Florida. This person is called the Principal Investigator. She is being
guided in this research by Dr. Kelly Werder. Other approved research staff may act on behalf of the Principal
Investigator. This study is being conducted at Qualtrics and is supported/sponsored by Dr. Kelly Werder. The
purpose of the study is to further research on crisis messaging and its effect on relationships amongst millennials
with the pharmaceutical industry. This research will include a 10-15 minute questionnaire that will be taken on
Qualtrics. You are being asked to take part because you are considered a millennial, being born between 19801996. Your participation is voluntary. You do not have to participate and may stop your participation at any
time. There will be no penalties or loss of benefits or opportunities if you do not participate or decide to stop once
you start. We do not know if you will receive any benefit from your participation. There is no cost to participate.
You will not be compensated for your participation. This research is considered minimal risk. Minimal risk means
that study risks are the same as the risks you face in daily life. Even if we publish the findings from this study, we
will keep your study information private and confidential. Anyone with the authority to look at your records must
keep them confidential.
Millennials are being asked to participate because there is limited research on their relationship with the industry
and it is something that should be looked into, since they will be the future generation to make decisions for the
industry. If you take part in this study, you will be asked to complete a survey online through Qualtrics. The study
will take between 10-15 minutes to complete. All data will be anonymous. You do not have to participate in this
research study. You should only take part in this study if you want to volunteer. You should not feel that there is
any pressure to take part in the study. You are free to participate in this research or withdraw at any time. There
will be no penalty or loss of benefits you are entitled to receive if you stop taking part in this study. You will receive
no benefit from this study. This research is considered to be minimal risk. We will do our best to keep your records
private and confidential. We cannot guarantee absolute confidentiality. Your personal information may be
disclosed if required by law. Certain people may need to see your study records. The only people who will be
allowed to see these records are the principal investigator, research team, advising team, and the USF Institutional
Review Board (IRB). It is possible, although unlikely, that unauthorized individuals could gain access to your
responses because you are responding online. Confidentiality will be maintained to the degree permitted by the
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technology used. No guarantees can be made regarding the interception of data sent via the Internet. However,
your participation in this online survey involves risks similar to a person’s everyday use of the Internet. If you
complete and submit an anonymous survey and later request your data be withdrawn, this may or may not be
possible as the researcher may be unable to extract anonymous data from the database. Your personal
information collected for this research will be kept as long as it is needed to conduct this research. Once your
participation in the research is over, your information will be stored in accordance with applicable policies and
regulations. Your permission to use your personal data will not expire unless you withdraw it in writing. You may
withdraw or take away your permission to use and disclose your information at any time. You do this by sending
written notice to the Principal Investigator at the following address: 8903 Citrus Village Drive, Apt 206, Tampa, FL
33626. While we are conducting the research study, we cannot let you see or copy the research information we
have about you. After the research is completed, you have a right to see the information about you, as allowed by
USF policies. If you have concerns about the use or storage of your personal information, you have a right to lodge
a complaint with the data supervisory authority in your country.
If you have any questions, concerns or complaints about this study, call Nikoletta Pappas at (302)-757-6069. If you
have questions about your rights, complaints, or issues as a person taking part in this study, call the USF IRB at
(813) 974-5638or contact the IRB by email atRSCH-IRB@usf.edu.
We may publish what we learn from this study. If we do, we will not let anyone know your name. We will not
publish anything else that would let people know who you are. You can print a copy of this consent form for your
records. I freely give my consent to take part in this study. I understand that by proceeding with this survey, I am
agreeing to take part in research and I am 18 years of age or older.
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Figure A. Daily Newspaper:
Please read the selected front page of the newspaper.

57

Figure C. PhRMA Public Statement Apology
Please read the following ad taken out by Pharmaceutical Research and
Manufacturers of America (PhRMA) in the newspaper.
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Instructions: Using the scale below, please indicate your level of agreement with the following
statements by writing the appropriate number in the blank provided.
__1__ __2__ __3__ __4__ __5__
Strongly
Strongly
Disagree
Agree
TRUST
____ 1. This industry treats people like me fairly and justly.
____ 2. Whenever this industry makes an important decision, I know it will be concerned
about people like me.
____ 3. This industry can be relied on to keep its promises.
____ 4. I believe that this industry takes the opinions of people like me into account when
making decisions.
____ 5. I feel very confident about this industry’s skills.
____ 6. This industry has the ability to accomplish what it says it will do.
CONTROL MUTUALITY
____7. This industry and people like me are attentive to what each other say.
____8. This industry believes the opinions of people like me are legitimate.
____9. In dealing with people like me, this industry has a tendency to throw its weight
around.
____10. This industry really listens to what people like me have to say.
____11. The management of this industry gives people like me enough say in the decisionmaking process.
COMMITTMENT
____12. I feel that this industry is trying to maintain a long-term commitment to people like
me.
____13. I can see that this industry wants to maintain a relationship with people like me.
____14. There is a long-lasting bond between this industry and people like me.
____15. Compared to other industries, I value my relationship with this industry more.
____16. I would rather work together with this industry than not.
SATISFACTION
____17. I am happy with this industry.
____18. Both the industry and people like me benefit from the relationship.
____19. Most people like me are happy in their interactions with this industry.
____20. Generally speaking, I am pleased with the relationship this industry has established
with people like me.
____21. Most people enjoy dealing with this industry.
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EXCHANGE RELATIONSHIPS
____22. Whenever this industry gives or offers something to people like me, it generally
expects something in return.
____23. Even though people like me have had a relationship with this industry for a long time,
it still expects something in return whenever it offers us a favor.
____24. This industry will compromise with people like me when it knows that it will gain
something.
____25. This industry takes care of people who are likely to reward the industry.
COMMUNAL RELATIONSHIPS
____26. This industry does not especially enjoy giving others aid.
____27. This industry is very concerned about the welfare of people like me.
____28. I feel that this industry takes advantage of people who are vulnerable.
____29. I think that this industry succeeds by stepping on other people.
____30. This industry helps people like me without expecting anything in return.
DENIAL MANIPULATION CHECK
____31. The industry attempted to remove connection between the themselves and the crisis.
____32. The industry argued that there was no ‘real’ crisis.
____33. The industry denied the truth to the crisis and refuted the charges of immoral
conduct.
REBUILD MANIPULATION CHECK
____34. The industry offered material and/or symbolic forms of aid to victims.
____35. The industry offered compensation or a full apology.
____36. The industry said and did things to benefit stakeholders.
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DEMOGRAPHICS
Instructions: Listed below are a few demographic questions about you that will help us to
understand your answers. Please select the appropriate response.
48. What is your age? __________
49. What is your sex? ________ Female ________ Male ________Other
50. What is your ethnicity?
c Caucasian

c African-American

c Hispanic

c Pacific Islander

c American Indian

c Asian

c Other
Thank you for your help in better understanding perceptions of your relationship with
the pharmaceutical industry!
This study investigated the effects of different crisis response messages. The scenarios you
were exposed to were created exclusively for this study, are hypothetical, and in no way reflect
the organization. After knowing the true nature of the study, you may choose to withdraw your
answers by selecting “yes” or your responses may be used in the study by selecting “no”. Thank
you again for your time.

61

Appendix D: Relationship Questionnaire - Silence
Thank you for agreeing to participate in this study!
We are interested in your personal opinions regarding your relationship with the
pharmaceutical industry. Please take a few minutes to review the next pages. Next, you will be
presented with a series of statements about your opinions. Please indicate your level of
agreement with each statement by selecting the appropriate response based on the scale
provided, next to each statement.
Please answer as honestly as possible. There are no right or wrong answers. Your responses to
this questionnaire will remain completely anonymous. The questionnaire will take about 10
minutes.
Thank you in advance for participating in this study!
______________________
Informed Consent Statement
You are being asked to take part in a research study. The information in this document should help you to decide if
you would like to participate. This study is being led by Nikoletta Pappas, who is a Graduate student at/in Mass
Communication at the University of South Florida. This person is called the Principal Investigator. She is being
guided in this research by Dr. Kelly Werder. Other approved research staff may act on behalf of the Principal
Investigator. This study is being conducted at Qualtrics and is supported/sponsored by Dr. Kelly Werder. The
purpose of the study is to further research on crisis messaging and its effect on relationships amongst millennials
with the pharmaceutical industry. This research will include a 10-15 minute questionnaire that will be taken on
Qualtrics. You are being asked to take part because you are considered a millennial, being born between 19801996. Your participation is voluntary. You do not have to participate and may stop your participation at any
time. There will be no penalties or loss of benefits or opportunities if you do not participate or decide to stop once
you start. We do not know if you will receive any benefit from your participation. There is no cost to participate.
You will not be compensated for your participation. This research is considered minimal risk. Minimal risk means
that study risks are the same as the risks you face in daily life. Even if we publish the findings from this study, we
will keep your study information private and confidential. Anyone with the authority to look at your records must
keep them confidential.
Millennials are being asked to participate because there is limited research on their relationship with the industry
and it is something that should be looked into, since they will be the future generation to make decisions for the
industry. If you take part in this study, you will be asked to complete a survey online through Qualtrics. The study
will take between 10-15 minutes to complete. All data will be anonymous. You do not have to participate in this
research study. You should only take part in this study if you want to volunteer. You should not feel that there is
any pressure to take part in the study. You are free to participate in this research or withdraw at any time. There
will be no penalty or loss of benefits you are entitled to receive if you stop taking part in this study. You will receive
no benefit from this study. This research is considered to be minimal risk. We will do our best to keep your records
private and confidential. We cannot guarantee absolute confidentiality. Your personal information may be
disclosed if required by law. Certain people may need to see your study records. The only people who will be
allowed to see these records are the principal investigator, research team, advising team, and the USF Institutional
Review Board (IRB). It is possible, although unlikely, that unauthorized individuals could gain access to your
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responses because you are responding online. Confidentiality will be maintained to the degree permitted by the
technology used. No guarantees can be made regarding the interception of data sent via the Internet. However,
your participation in this online survey involves risks similar to a person’s everyday use of the Internet. If you
complete and submit an anonymous survey and later request your data be withdrawn, this may or may not be
possible as the researcher may be unable to extract anonymous data from the database. Your personal
information collected for this research will be kept as long as it is needed to conduct this research. Once your
participation in the research is over, your information will be stored in accordance with applicable policies and
regulations. Your permission to use your personal data will not expire unless you withdraw it in writing. You may
withdraw or take away your permission to use and disclose your information at any time. You do this by sending
written notice to the Principal Investigator at the following address: 8903 Citrus Village Drive, Apt 206, Tampa, FL
33626. While we are conducting the research study, we cannot let you see or copy the research information we
have about you. After the research is completed, you have a right to see the information about you, as allowed by
USF policies. If you have concerns about the use or storage of your personal information, you have a right to lodge
a complaint with the data supervisory authority in your country.
If you have any questions, concerns or complaints about this study, call Nikoletta Pappas at (302)-757-6069. If you
have questions about your rights, complaints, or issues as a person taking part in this study, call the USF IRB at
(813) 974-5638or contact the IRB by email atRSCH-IRB@usf.edu.
We may publish what we learn from this study. If we do, we will not let anyone know your name. We will not
publish anything else that would let people know who you are. You can print a copy of this consent form for your
records. I freely give my consent to take part in this study. I understand that by proceeding with this survey, I am
agreeing to take part in research and I am 18 years of age or older.
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Figure A. Daily Newspaper:
Please read the selected front page of the newspaper.
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Instructions: Using the scale below, please indicate your level of agreement with the following
statements by writing the appropriate number in the blank provided.
__1__ __2__ __3__ __4__ __5__
Strongly
Strongly
Disagree
Agree
TRUST
____ 1. This industry treats people like me fairly and justly.
____ 2. Whenever this industry makes an important decision, I know it will be concerned
about people like me.
____ 3. This industry can be relied on to keep its promises.
____ 4. I believe that this industry takes the opinions of people like me into account when
making decisions.
____ 5. I feel very confident about this industry’s skills.
____ 6. This industry has the ability to accomplish what it says it will do.
CONTROL MUTUALITY
____7. This industry and people like me are attentive to what each other say.
____8. This industry believes the opinions of people like me are legitimate.
____9. In dealing with people like me, this industry has a tendency to throw its weight
around.
____10. This industry really listens to what people like me have to say.
____11. The management of this industry gives people like me enough say in the decisionmaking process.
COMMITTMENT
____12. I feel that this industry is trying to maintain a long-term commitment to people like
me.
____13. I can see that this industry wants to maintain a relationship with people like me.
____14. There is a long-lasting bond between this industry and people like me.
____15. Compared to other industries, I value my relationship with this industry more.
____16. I would rather work together with this industry than not.
SATISFACTION
____17. I am happy with this industry.
____18. Both the industry and people like me benefit from the relationship.
____19. Most people like me are happy in their interactions with this industry.
____20. Generally speaking, I am pleased with the relationship this industry has established
with people like me.
____21. Most people enjoy dealing with this industry.
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EXCHANGE RELATIONSHIPS
____22. Whenever this industry gives or offers something to people like me, it generally
expects something in return.
____23. Even though people like me have had a relationship with this industry for a long time,
it still expects something in return whenever it offers us a favor.
____24. This industry will compromise with people like me when it knows that it will gain
something.
____25. This industry takes care of people who are likely to reward the industry.
COMMUNAL RELATIONSHIPS
____26. This industry does not especially enjoy giving others aid.
____27. This industry is very concerned about the welfare of people like me.
____28. I feel that this industry takes advantage of people who are vulnerable.
____29. I think that this industry succeeds by stepping on other people.
____30. This industry helps people like me without expecting anything in return.
DENIAL MANIPULATION CHECK
____31. The industry attempted to remove connection between the themselves and the crisis.
____32. The industry argued that there was no ‘real’ crisis.
____33. The industry denied the truth to the crisis and refuted the charges of immoral
conduct.
REBUILD MANIPULATION CHECK
____34. The industry offered material and/or symbolic forms of aid to victims.
____35. The industry offered compensation or a full apology.
____36. The industry said and did things to benefit stakeholders.
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DEMOGRAPHICS
Instructions: Listed below are a few demographic questions about you that will help us to
understand your answers. Please select the appropriate response.
48. What is your age? __________
49. What is your sex? ________ Female ________ Male ________Other
50. What is your ethnicity?
c Caucasian

c African-American

c Hispanic

c Pacific Islander

c American Indian

c Asian

c Other
Thank you for your help in better understanding perceptions of your relationship with
the pharmaceutical industry!
This study investigated the effects of different crisis response messages. The scenarios you
were exposed to were created exclusively for this study, are hypothetical, and in no way reflect
the organization. After knowing the true nature of the study, you may choose to withdraw your
answers by selecting “yes” or your responses may be used in the study by selecting “no”. Thank
you again for your time.
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Appendix E: Relationship Questionnaire – Control
Thank you for agreeing to participate in this study!
We are interested in your personal opinions regarding your relationship with the
pharmaceutical industry. Please take a few minutes to review the next pages. Next, you will be
presented with a series of statements about your opinions. Please indicate your level of
agreement with each statement by selecting the appropriate response based on the scale
provided, next to each statement.
Please answer as honestly as possible. There are no right or wrong answers. Your responses to
this questionnaire will remain completely anonymous. The questionnaire will take about 10
minutes.
Thank you in advance for participating in this study!
______________________
Informed Consent Statement
You are being asked to take part in a research study. The information in this document should help you to decide if
you would like to participate. This study is being led by Nikoletta Pappas, who is a Graduate student at/in Mass
Communication at the University of South Florida. This person is called the Principal Investigator. She is being
guided in this research by Dr. Kelly Werder. Other approved research staff may act on behalf of the Principal
Investigator. This study is being conducted at Qualtrics and is supported/sponsored by Dr. Kelly Werder. The
purpose of the study is to further research on crisis messaging and its effect on relationships amongst millennials
with the pharmaceutical industry. This research will include a 10-15 minute questionnaire that will be taken on
Qualtrics. You are being asked to take part because you are considered a millennial, being born between 19801996. Your participation is voluntary. You do not have to participate and may stop your participation at any
time. There will be no penalties or loss of benefits or opportunities if you do not participate or decide to stop once
you start. We do not know if you will receive any benefit from your participation. There is no cost to participate.
You will not be compensated for your participation. This research is considered minimal risk. Minimal risk means
that study risks are the same as the risks you face in daily life. Even if we publish the findings from this study, we
will keep your study information private and confidential. Anyone with the authority to look at your records must
keep them confidential.
Millennials are being asked to participate because there is limited research on their relationship with the industry
and it is something that should be looked into, since they will be the future generation to make decisions for the
industry. If you take part in this study, you will be asked to complete a survey online through Qualtrics. The study
will take between 10-15 minutes to complete. All data will be anonymous. You do not have to participate in this
research study. You should only take part in this study if you want to volunteer. You should not feel that there is
any pressure to take part in the study. You are free to participate in this research or withdraw at any time. There
will be no penalty or loss of benefits you are entitled to receive if you stop taking part in this study. You will receive
no benefit from this study. This research is considered to be minimal risk. We will do our best to keep your records
private and confidential. We cannot guarantee absolute confidentiality. Your personal information may be
disclosed if required by law. Certain people may need to see your study records. The only people who will be
allowed to see these records are the principal investigator, research team, advising team, and the USF Institutional
Review Board (IRB). It is possible, although unlikely, that unauthorized individuals could gain access to your
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responses because you are responding online. Confidentiality will be maintained to the degree permitted by the
technology used. No guarantees can be made regarding the interception of data sent via the Internet. However,
your participation in this online survey involves risks similar to a person’s everyday use of the Internet. If you
complete and submit an anonymous survey and later request your data be withdrawn, this may or may not be
possible as the researcher may be unable to extract anonymous data from the database. Your personal
information collected for this research will be kept as long as it is needed to conduct this research. Once your
participation in the research is over, your information will be stored in accordance with applicable policies and
regulations. Your permission to use your personal data will not expire unless you withdraw it in writing. You may
withdraw or take away your permission to use and disclose your information at any time. You do this by sending
written notice to the Principal Investigator at the following address: 8903 Citrus Village Drive, Apt 206, Tampa, FL
33626. While we are conducting the research study, we cannot let you see or copy the research information we
have about you. After the research is completed, you have a right to see the information about you, as allowed by
USF policies. If you have concerns about the use or storage of your personal information, you have a right to lodge
a complaint with the data supervisory authority in your country.
If you have any questions, concerns or complaints about this study, call Nikoletta Pappas at (302)-757-6069. If you
have questions about your rights, complaints, or issues as a person taking part in this study, call the USF IRB at
(813) 974-5638or contact the IRB by email atRSCH-IRB@usf.edu.
We may publish what we learn from this study. If we do, we will not let anyone know your name. We will not
publish anything else that would let people know who you are. You can print a copy of this consent form for your
records. I freely give my consent to take part in this study. I understand that by proceeding with this survey, I am
agreeing to take part in research and I am 18 years of age or older.
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Instructions: Using the scale below, please indicate your level of agreement with the following
statements by writing the appropriate number in the blank provided.
__1__ __2__ __3__ __4__ __5__
Strongly
Strongly
Disagree
Agree
TRUST
____ 1. This industry treats people like me fairly and justly.
____ 2. Whenever this industry makes an important decision, I know it will be concerned
about people like me.
____ 3. This industry can be relied on to keep its promises.
____ 4. I believe that this industry takes the opinions of people like me into account when
making decisions.
____ 5. I feel very confident about this industry’s skills.
____ 6. This industry has the ability to accomplish what it says it will do.
CONTROL MUTUALITY
____7. This industry and people like me are attentive to what each other say.
____8. This industry believes the opinions of people like me are legitimate.
____9. In dealing with people like me, this industry has a tendency to throw its weight
around.
____10. This industry really listens to what people like me have to say.
____11. The management of this industry gives people like me enough say in the decisionmaking process.
COMMITTMENT
____12. I feel that this industry is trying to maintain a long-term commitment to people like
me.
____13. I can see that this industry wants to maintain a relationship with people like me.
____14. There is a long-lasting bond between this industry and people like me.
____15. Compared to other industries, I value my relationship with this industry more.
____16. I would rather work together with this industry than not.
SATISFACTION
____17. I am happy with this industry.
____18. Both the industry and people like me benefit from the relationship.
____19. Most people like me are happy in their interactions with this industry.
____20. Generally speaking, I am pleased with the relationship this industry has established
with people like me.
____21. Most people enjoy dealing with this industry.
EXCHANGE RELATIONSHIPS
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EXCHANGE RELATIONSHIPS
____22. Whenever this industry gives or offers something to people like me, it generally
expects something in return.
____23. Even though people like me have had a relationship with this industry for a long time,
it still expects something in return whenever it offers us a favor.
____24. This industry will compromise with people like me when it knows that it will gain
something.
____25. This industry takes care of people who are likely to reward the industry.
COMMUNAL RELATIONSHIPS
____26. This industry does not especially enjoy giving others aid.
____27. This industry is very concerned about the welfare of people like me.
____28. I feel that this industry takes advantage of people who are vulnerable.
____29. I think that this industry succeeds by stepping on other people.
____30. This industry helps people like me without expecting anything in return.
DENIAL MANIPULATION CHECK
____31. The industry attempted to remove connection between the themselves and the crisis.
____32. The industry argued that there was no ‘real’ crisis.
____33. The industry denied the truth to the crisis and refuted the charges of immoral
conduct.
REBUILD MANIPULATION CHECK
____34. The industry offered material and/or symbolic forms of aid to victims.
____35. The industry offered compensation or a full apology.
____36. The industry said and did things to benefit stakeholders.
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DEMOGRAPHICS
Instructions: Listed below are a few demographic questions about you that will help us to
understand your answers. Please write or select the appropriate response.
48. What is your age? __________
49. What is your sex? ________ Female ________ Male ________Other
50. What is your ethnicity?
c Caucasian

c African-American

c Hispanic

c Pacific Islander

c American Indian

c Asian

c Other
Thank you for your help in better understanding perceptions of your relationship with
the pharmaceutical industry!
This study investigated the effects of different crisis response messages. The scenarios you
were exposed to were created exclusively for this study, are hypothetical, and in no way reflect
the organization. After knowing the true nature of the study, you may choose to withdraw your
answers by selecting “yes” or your responses may be used in the study by selecting “no”. Thank
you again for your time.
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